'Buy China' In Procurement Schemes - Should You Worry?

A recent trade group report points to a rising and alarming "Buy China" trend in procurement rounds in the country. Although largely in medical device bidding, it may potentially affect the pharma sector, an analysis from the recent “4+7” centralized bidding scheme show.

China
'Buy China' Procurement Puts Foreign Companies At A Disadvantage, EUCCC Says • Source: Shutterstock

More from China

More from Focus On Asia